Perspectives of nonalcoholic fatty liver disease research: a personal point of view

by Amedeo Lonardo, Stefano Ballestri
Published 2020-06-01

Alcohol and Steatosis: The Japanese Paradox

by A. Lonardo, S. Ballestri, D. Romagnoli, F. Nascimbeni
Published 2016-06-01

Influenza Del Calcio Sulla Morfologia Degli Eritrociti Urinari

by M. Ballestri, A. Baraldi, A. D'Amelio, D. Bonucchi
Published 1998-04-01

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight

by Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Giovanni Targher, Amedeo Lonardo
Published 2016-03-01

Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?

by Fabio Nascimbeni, Dante Romagnoli, Stefano Ballestri, Enrica Baldelli, Simonetta Lugari, Valentina Sirotti, Valentina Giampaoli, Amedeo Lonardo
Published 2018-02-01

Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models

by Foglietta F, Spagnoli GC, Muraro MG, Ballestri M, Guerrini A, Ferroni C, Aluigi A, Sotgiu G, Varchi G
Published 2018-08-01

Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease

by Stefano Ballestri, Alessandro Mantovani, Enrica Baldelli, Simonetta Lugari, Mauro Maurantonio, Fabio Nascimbeni, Alessandra Marrazzo, Dante Romagnoli, Giovanni Targher, Amedeo Lonardo
Published 2021-01-01

Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model

by Canaparo R, Varchi G, Ballestri M, Foglietta F, Sotgiu G, Guerrini A, Francovich A, Civera P, Frairia R, Serpe L
Published 2013-11-01

Hepatitis C Virus-Infected Patients Are ‘Spared’ from the Metabolic Syndrome but Not from Insulin Resistance. A Comparative Study of Nonalcoholic Fatty Liver Disease and Hepatitis...

by Amedeo Lonardo, Stefano Ballestri, Luigi E Adinolfi, Enrico Violi, Lucia Carulli, Silvia Lombardini, Federica Scaglioni, Matteo Ricchi, Giuseppe Ruggiero, Paola Loria
Published 2009-01-01

COVID-19 Sepsis and Microcirculation Dysfunction

by Antonio Colantuoni, Romeo Martini, Patrizia Caprari, Marco Ballestri, Pier Leopoldo Capecchi, Agostino Gnasso, Rosalia Lo Presti, Antonella Marcoccia, Marco Rossi, Gregorio Caimi
Published 2020-06-01

Functionalized Keratin as Nanotechnology-Based Drug Delivery System for the Pharmacological Treatment of Osteosarcoma

by Elisa Martella, Claudia Ferroni, Andrea Guerrini, Marco Ballestri, Marta Columbaro, Spartaco Santi, Giovanna Sotgiu, Massimo Serra, Davide Maria Donati, Enrico Lucarelli, Greta Varchi, Serena Duchi
Published 2018-11-01

Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19

by Francesco Fontana, Silvia Cazzato, Silvia Giovanella, Marco Ballestri, Marco Leonelli, Giacomo Mori, Gaetano Alfano, Giulia Ligabue, Riccardo Magistroni, Giovanna Cenacchi, Riccardo Antoniotti, Decenzio Bonucchi, Gianni Cappelli
Published 2020-10-01

Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications

by Claudio Tana, Stefano Ballestri, Fabrizio Ricci, Angelo Di Vincenzo, Andrea Ticinesi, Sabina Gallina, Maria Adele Giamberardino, Francesco Cipollone, Richard Sutton, Roberto Vettor, Artur Fedorowski, Tiziana Meschi
Published 2019-08-01

Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model

by Stefania Lenna, Chiara Bellotti, Serena Duchi, Elisa Martella, Marta Columbaro, Barbara Dozza, Marco Ballestri, Andrea Guerrini, Giovanna Sotgiu, Tommaso Frisoni, Luca Cevolani, Greta Varchi, Mauro Ferrari, Davide Maria Donati, Enrico Lucarelli
Published 2020-02-01